nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—UGT1A3—Estrogen metabolism—COMT—conduct disorder	0.0491	0.0491	CbGpPWpGaD
Morphine—UGT2B7—Estrogen metabolism—COMT—conduct disorder	0.0418	0.0418	CbGpPWpGaD
Morphine—UGT1A1—Estrogen metabolism—COMT—conduct disorder	0.034	0.034	CbGpPWpGaD
Morphine—UGT1A8—Phase II conjugation—COMT—conduct disorder	0.0295	0.0295	CbGpPWpGaD
Morphine—UGT2B4—Phase II conjugation—COMT—conduct disorder	0.0258	0.0258	CbGpPWpGaD
Morphine—UGT2B15—Phase II conjugation—COMT—conduct disorder	0.0258	0.0258	CbGpPWpGaD
Morphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0237	0.0237	CbGpPWpGaD
Morphine—OPRL1—Circadian rythm related genes—SLC6A4—conduct disorder	0.0201	0.0201	CbGpPWpGaD
Morphine—OPRL1—Circadian rythm related genes—DRD4—conduct disorder	0.0189	0.0189	CbGpPWpGaD
Morphine—OPRL1—GPCR ligand binding—CGA—conduct disorder	0.018	0.018	CbGpPWpGaD
Morphine—UGT1A8—Biological oxidations—COMT—conduct disorder	0.0173	0.0173	CbGpPWpGaD
Morphine—UGT1A8—Biological oxidations—MAOA—conduct disorder	0.0171	0.0171	CbGpPWpGaD
Morphine—OPRL1—G alpha (i) signalling events—DRD4—conduct disorder	0.0167	0.0167	CbGpPWpGaD
Morphine—OPRL1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0155	0.0155	CbGpPWpGaD
Morphine—UGT2B4—Biological oxidations—COMT—conduct disorder	0.0151	0.0151	CbGpPWpGaD
Morphine—UGT2B15—Biological oxidations—COMT—conduct disorder	0.0151	0.0151	CbGpPWpGaD
Morphine—UGT2B4—Biological oxidations—MAOA—conduct disorder	0.015	0.015	CbGpPWpGaD
Morphine—UGT2B15—Biological oxidations—MAOA—conduct disorder	0.015	0.015	CbGpPWpGaD
Morphine—UGT2B4—Metapathway biotransformation—COMT—conduct disorder	0.0149	0.0149	CbGpPWpGaD
Morphine—UGT1A3—Phase II conjugation—COMT—conduct disorder	0.0138	0.0138	CbGpPWpGaD
Morphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0133	0.0133	CbGpPWpGaD
Morphine—UGT1A3—NRF2 pathway—SLC6A4—conduct disorder	0.0122	0.0122	CbGpPWpGaD
Morphine—UGT2B7—Phase II conjugation—COMT—conduct disorder	0.0117	0.0117	CbGpPWpGaD
Morphine—UGT2B7—NRF2 pathway—SLC6A4—conduct disorder	0.0103	0.0103	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—CGA—conduct disorder	0.0102	0.0102	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0101	0.0101	CbGpPWpGaD
Morphine—OPRL1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.0101	0.0101	CbGpPWpGaD
Morphine—OPRL1—GPCR ligand binding—DRD4—conduct disorder	0.0101	0.0101	CbGpPWpGaD
Morphine—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.00995	0.00995	CbGpPWpGaD
Morphine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00995	0.00995	CbGpPWpGaD
Morphine—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.0096	0.0096	CbGpPWpGaD
Morphine—UGT1A1—Phase II conjugation—COMT—conduct disorder	0.00954	0.00954	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—CGA—conduct disorder	0.00925	0.00925	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00886	0.00886	CbGpPWpGaD
Morphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00865	0.00865	CbGpPWpGaD
Morphine—UGT1A1—NRF2 pathway—SLC6A4—conduct disorder	0.0084	0.0084	CbGpPWpGaD
Morphine—UGT1A3—Biological oxidations—COMT—conduct disorder	0.00808	0.00808	CbGpPWpGaD
Morphine—UGT1A3—Biological oxidations—MAOA—conduct disorder	0.00802	0.00802	CbGpPWpGaD
Morphine—UGT1A3—Metapathway biotransformation—COMT—conduct disorder	0.00797	0.00797	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—CGA—conduct disorder	0.00769	0.00769	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00749	0.00749	CbGpPWpGaD
Morphine—OPRD1—G alpha (i) signalling events—DRD4—conduct disorder	0.00712	0.00712	CbGpPWpGaD
Morphine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00687	0.00687	CbGpPWpGaD
Morphine—UGT2B7—Biological oxidations—COMT—conduct disorder	0.00687	0.00687	CbGpPWpGaD
Morphine—UGT2B7—Biological oxidations—MAOA—conduct disorder	0.00682	0.00682	CbGpPWpGaD
Morphine—UGT2B7—Metapathway biotransformation—COMT—conduct disorder	0.00677	0.00677	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—CGA—conduct disorder	0.00675	0.00675	CbGpPWpGaD
Morphine—OPRD1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0066	0.0066	CbGpPWpGaD
Morphine—OPRL1—GPCR ligand binding—HTR2A—conduct disorder	0.00659	0.00659	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—CGA—conduct disorder	0.00654	0.00654	CbGpPWpGaD
Morphine—OPRL1—Circadian rythm related genes—EP300—conduct disorder	0.00653	0.00653	CbGpPWpGaD
Morphine—OPRK1—G alpha (i) signalling events—DRD4—conduct disorder	0.00624	0.00624	CbGpPWpGaD
Morphine—OPRK1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00579	0.00579	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—CGA—conduct disorder	0.00571	0.00571	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—CGA—conduct disorder	0.00571	0.00571	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—DRD4—conduct disorder	0.0057	0.0057	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—CGA—conduct disorder	0.0057	0.0057	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00566	0.00566	CbGpPWpGaD
Morphine—UGT1A1—Biological oxidations—COMT—conduct disorder	0.00558	0.00558	CbGpPWpGaD
Morphine—UGT1A1—Biological oxidations—MAOA—conduct disorder	0.00554	0.00554	CbGpPWpGaD
Morphine—UGT1A1—Metapathway biotransformation—COMT—conduct disorder	0.0055	0.0055	CbGpPWpGaD
Morphine—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00549	0.00549	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CGA—conduct disorder	0.00546	0.00546	CbGpPWpGaD
Morphine—OPRM1—G alpha (i) signalling events—DRD4—conduct disorder	0.00527	0.00527	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—DRD4—conduct disorder	0.00518	0.00518	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00496	0.00496	CbGpPWpGaD
Morphine—OPRM1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00489	0.00489	CbGpPWpGaD
Morphine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00451	0.00451	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—WASF1—conduct disorder	0.00438	0.00438	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—CGA—conduct disorder	0.00435	0.00435	CbGpPWpGaD
Morphine—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00431	0.00431	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—DRD4—conduct disorder	0.00431	0.00431	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00419	0.00419	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CGA—conduct disorder	0.00395	0.00395	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CGA—conduct disorder	0.00381	0.00381	CbGpPWpGaD
Morphine—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00378	0.00378	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—DRD4—conduct disorder	0.00378	0.00378	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—HTR2A—conduct disorder	0.00372	0.00372	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00369	0.00369	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CGA—conduct disorder	0.00346	0.00346	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—HTR2A—conduct disorder	0.00338	0.00338	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00324	0.00324	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CGA—conduct disorder	0.00322	0.00322	CbGpPWpGaD
Morphine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00319	0.00319	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—DRD4—conduct disorder	0.00319	0.00319	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—DRD4—conduct disorder	0.00306	0.00306	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—CGA—conduct disorder	0.00306	0.00306	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—COMT—conduct disorder	0.00295	0.00295	CbGpPWpGaD
Morphine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00295	0.00295	CbGpPWpGaD
Morphine—CYP2C8—Biological oxidations—COMT—conduct disorder	0.00294	0.00294	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—MAOA—conduct disorder	0.00293	0.00293	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CGA—conduct disorder	0.00293	0.00293	CbGpPWpGaD
Morphine—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00292	0.00292	CbGpPWpGaD
Morphine—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.0029	0.0029	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—HTR2A—conduct disorder	0.00281	0.00281	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00274	0.00274	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—CGA—conduct disorder	0.0026	0.0026	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—COMT—conduct disorder	0.00258	0.00258	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—COMT—conduct disorder	0.00258	0.00258	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—MAOA—conduct disorder	0.00256	0.00256	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—MAOA—conduct disorder	0.00256	0.00256	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0025	0.0025	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—HTR2A—conduct disorder	0.00247	0.00247	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—DRD4—conduct disorder	0.00244	0.00244	CbGpPWpGaD
Morphine—CYP2D6—Biological oxidations—COMT—conduct disorder	0.00241	0.00241	CbGpPWpGaD
Morphine—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.0024	0.0024	CbGpPWpGaD
Morphine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.00238	0.00238	CbGpPWpGaD
Morphine—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00236	0.00236	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CGA—conduct disorder	0.00233	0.00233	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—DRD4—conduct disorder	0.00221	0.00221	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—DRD4—conduct disorder	0.00214	0.00214	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CGA—conduct disorder	0.00211	0.00211	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—HTR2A—conduct disorder	0.00208	0.00208	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CGA—conduct disorder	0.00205	0.00205	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—HTR2A—conduct disorder	0.002	0.002	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00194	0.00194	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—DRD4—conduct disorder	0.00194	0.00194	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—WASF1—conduct disorder	0.00187	0.00187	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—DRD4—conduct disorder	0.0018	0.0018	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CGA—conduct disorder	0.00173	0.00173	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—WASF1—conduct disorder	0.00164	0.00164	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—DRD4—conduct disorder	0.00164	0.00164	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—HTR2A—conduct disorder	0.00159	0.00159	CbGpPWpGaD
Morphine—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00158	0.00158	CbGpPWpGaD
Morphine—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00157	0.00157	CbGpPWpGaD
Morphine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00156	0.00156	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—HTR2A—conduct disorder	0.00144	0.00144	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—HTR2A—conduct disorder	0.00139	0.00139	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—WASF1—conduct disorder	0.00139	0.00139	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—COMT—conduct disorder	0.00138	0.00138	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—MAOA—conduct disorder	0.00137	0.00137	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—DRD4—conduct disorder	0.00131	0.00131	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—HTR2A—conduct disorder	0.00127	0.00127	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—EP300—conduct disorder	0.00127	0.00127	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—HTR2A—conduct disorder	0.00118	0.00118	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—COMT—conduct disorder	0.00117	0.00117	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—MAOA—conduct disorder	0.00117	0.00117	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—DRD4—conduct disorder	0.00115	0.00115	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CGA—conduct disorder	0.00111	0.00111	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—EP300—conduct disorder	0.00111	0.00111	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—EP300—conduct disorder	0.00111	0.00111	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—HTR2A—conduct disorder	0.00107	0.00107	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—EP300—conduct disorder	0.00106	0.00106	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00101	0.00101	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CGA—conduct disorder	0.00097	0.00097	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—DRD4—conduct disorder	0.000968	0.000968	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—COMT—conduct disorder	0.000954	0.000954	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—MAOA—conduct disorder	0.000948	0.000948	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CGA—conduct disorder	0.000914	0.000914	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—HTR2A—conduct disorder	0.000852	0.000852	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—HTR2A—conduct disorder	0.000747	0.000747	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HTR2A—conduct disorder	0.000632	0.000632	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CGA—conduct disorder	0.000598	0.000598	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—EP300—conduct disorder	0.000592	0.000592	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—EP300—conduct disorder	0.000504	0.000504	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—COMT—conduct disorder	0.000503	0.000503	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—MAOA—conduct disorder	0.000499	0.000499	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000484	0.000484	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EP300—conduct disorder	0.000452	0.000452	CbGpPWpGaD
Morphine—ABCB1—Metabolism—COMT—conduct disorder	0.000438	0.000438	CbGpPWpGaD
Morphine—ABCB1—Metabolism—MAOA—conduct disorder	0.000435	0.000435	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—COMT—conduct disorder	0.000413	0.000413	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—MAOA—conduct disorder	0.00041	0.00041	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—EP300—conduct disorder	0.000409	0.000409	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EP300—conduct disorder	0.000396	0.000396	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EP300—conduct disorder	0.000335	0.000335	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—COMT—conduct disorder	0.00027	0.00027	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—MAOA—conduct disorder	0.000268	0.000268	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—EP300—conduct disorder	0.000216	0.000216	CbGpPWpGaD
Morphine—ABCB1—Metabolism—EP300—conduct disorder	0.000188	0.000188	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—EP300—conduct disorder	0.000177	0.000177	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—EP300—conduct disorder	0.000116	0.000116	CbGpPWpGaD
